Rapid Detection of Pseudomonas Aeruginosa in Bronchoalveolar Lavage Fluid Using Label-free Single-particle Imaging Technology and Assessment of Post-treatment Efficacy in Patients With Pseudomonas Aeruginosa Infection

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorThe First Affiliated Hospital with Nanjing Medical University

About this trial

The aim of this study is to observe specimens of bronchoalveolar lavage fluid from patients using a reflection enhanced dark-field scattering microscopy. By observing parameters such as the size, morphology, scattering intensity, and movement speed of pathogens, combined with the clinical characteristics of patients, a rapid diagnosis of Pseudomonas aeruginosa infection can be made. At the same time, the bronchoalveolar lavage fluid samples of patients infected with Pseudomonas aeruginosa before and after treatment were compared, and the quantity and vitality of Pseudomonas aeruginosa were observed to judge the efficacy of antibiotics.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 18 years and above

After admission, Pseudomonas aeruginosa was cultured in bronchoalveolar lavage fluid or lower respiratory tract aspirates

Disqualifiers

Age under 18 years old or over 90 years old

Pregnancy, lactation period -

Trial population

Suspected or diagnosed patients with pulmonary infection caused by Pseudomonas aeruginosa

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • bronchoscopy

    Procedure/Surgery

    We will perform bronchoscopy and collect bronchoalveolar lavage fluid (BALF)

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

The size of pathogens

Measure the size of pathogens

Time frame
From enrollment to the end of treatment at 2 weeks
2

scattering intensity of pathogen

Determine the shape of pathogens through scattering intensity

Time frame
From enrollment to the end of treatment at 2 weeks
3

movement speed of pathogens

Measure the movement speed of pathogens, such as flagellates like Pseudomonas aeruginosa, which have a fast movement speed

Time frame
From enrollment to the end of treatment at 2 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: